CyTuVax is a company that develops therapeutic vaccines against cancer and protective vaccines against viral and bacterial pathogens. It offers vaccination platform technology based on depot-attached cytokines as an immune stimulator. The CyTuVax vaccines generate immune responses and are designed for cancer immunotherapy.